Effectiveness of Wearable Digital Therapeutics in Improving Sleep Outcomes Among Individuals With Insomnia: Systematic Review and Meta-Analysis of Randomized Controlled Trials - Report - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Efficacy of Wearable Digital Therapeutics in Enhancing Sleep Quality for Individuals with Insomnia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Clinical Report: Efficacy of Wearable Digital Therapeutics in Enhancing Sleep Quality
Overview
This systematic review and meta-analysis evaluates the efficacy of wearable digital therapeutics for improving sleep quality in individuals with insomnia. The findings suggest potential effectiveness in enhancing sleep outcomes across various populations.
Background
Insomnia is a prevalent sleep disorder affecting 10% to 20% of adults, with significant implications for mental health and quality of life. The economic burden of insomnia is substantial, with costs exceeding $100 billion annually in the U.S. alone, as reported in various studies.
Data Highlights
No numerical data was provided in the source material.
Key Findings
Wearable digital therapeutics can enhance sleep quality in individuals with insomnia.
Insomnia is linked to increased risks of mental disorders and reduced quality of life.
Digital health interventions provide scalable methods for managing sleep disturbances.
Robust empirical evidence supports cognitive behavioral therapy for insomnia (CBT-I) as a first-line treatment.
There is a global scarcity of trained CBT-I therapists, limiting broad implementation.
Clinical Implications
Healthcare providers should consider the role of wearable digital therapeutics in insomnia management strategies.
Conclusion
Wearable digital therapeutics may improve sleep quality in individuals with insomnia.